Cancer Society Urges More Men to Get Tested for Prostate Cancer

The American Cancer Society has issued its most definitive prostate cancer screening guidelines to date, moving beyond vague recommendations to tell American men exactly when and how often they should get tested for a disease that kills more than 34,000 men annually.

New Testing Schedule Targets High-Risk Groups

The guidelines released Thursday recommend that all men at average risk begin prostate-specific antigen blood testing every two years between ages 50 and 69. Black men and those with strong family histories of the disease should start earlier at age 45. The organization based its updated stance on fresh evidence showing PSA screening actually reduces deaths from prostate cancer, a significant shift from previous uncertainty about the test’s effectiveness.

Dr. William Dahut, the organization’s chief scientific officer and medical oncologist, emphasized the importance of the change. He stated the society now has clear evidence that PSA testing decreases the chance of dying from prostate cancer. The guidelines also recommend annual screening for men with PSA levels at 3.0 or higher, while those with levels at 2.5 or lower should continue biennial testing.

Addressing Stark Racial Disparities

The earlier screening recommendation for Black men addresses troubling statistics from the Centers for Disease Control and Prevention. Black men face higher rates of developing prostate cancer and are more than twice as likely to die from the disease compared to other men. With more than 266,000 new cases reported in 2023 alone, prostate cancer remains one of the most common cancers affecting American men.

Men between 70 and 74 should discuss screening decisions with their physicians, weighing individual health factors. The guidelines recommend men 75 and older, or those not expected to live another decade, discontinue screening since prostate cancers typically grow slowly and treatments can cause serious side effects including urinary incontinence and erectile dysfunction.

Medical Community Remains Divided

The American Cancer Society’s specific recommendations stand in contrast to other medical organizations. The American Academy of Family Physicians opposes PSA screening entirely, while the U.S. Preventive Services Task Force leaves testing decisions to individual doctors and patients. The American Urological Association recommends screening between ages 55 and 69, but suggests high-risk men start at 40. These conflicting guidelines reflect ongoing debate about balancing early detection benefits against risks of overdiagnosis, false positives, and unnecessary treatments that may cause more harm than good in cases where slow-growing cancers might never become life-threatening.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Recent

Weekly Wrap

Trending

You may also like...

RELATED ARTICLES